FBU:NZXFletcher Building Limited Analysis
Data as of 2026-03-15 - not real-time
NZ$3.42
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Fletcher Building’s share price is currently perched between its 20‑day and 50‑day moving averages, indicating a lack of clear directional bias. The 14‑day RSI sits in the mid‑40s, just under the neutral threshold, suggesting modest downside momentum. A bearish MACD histogram reinforces this cautious stance, while the price remains above the identified support level but below the near‑term resistance zone. Volume has been trending lower, which may limit short‑term price swings. Volatility over the past month is elevated, reflecting the sector’s cyclical nature. Nevertheless, the stock’s low beta points to limited exposure to broader market moves.
Fundamentally, the company’s DCF‑derived fair value lies below the current market price, implying only modest upside potential of roughly five percent. Revenue growth is flat and profit margins remain negative, though forward earnings estimates have turned positive, aligning the valuation more with a value‑oriented play than a growth story. The balance sheet carries a sizeable debt load relative to equity, and free cash flow is negative, which raises concerns about cash generation. With no dividend and a payout ratio of zero, income‑focused investors have little to rely on. Given the neutral technical setup, limited upside, and the company’s solid asset base, the stock appears fairly priced at present. We therefore recommend a cautious approach, holding the position in the near term while monitoring for any catalyst that could shift sentiment.
Fundamentally, the company’s DCF‑derived fair value lies below the current market price, implying only modest upside potential of roughly five percent. Revenue growth is flat and profit margins remain negative, though forward earnings estimates have turned positive, aligning the valuation more with a value‑oriented play than a growth story. The balance sheet carries a sizeable debt load relative to equity, and free cash flow is negative, which raises concerns about cash generation. With no dividend and a payout ratio of zero, income‑focused investors have little to rely on. Given the neutral technical setup, limited upside, and the company’s solid asset base, the stock appears fairly priced at present. We therefore recommend a cautious approach, holding the position in the near term while monitoring for any catalyst that could shift sentiment.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Technical indicators show neutral bias
- Decreasing volume limits price movement
- Price above support but below resistance
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Modest upside relative to fair value
- Value‑oriented fundamentals
- Low beta reduces market‑wide risk
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong asset base and market position
- Potential sector recovery
- Long‑term cash flow improvement prospects
Key Metrics & Analysis
Financial Health
Revenue Growth0.50%
Profit Margin-4.22%
P/E Ratio17.2
ROE-6.04%
ROA2.93%
Debt/Equity68.64
P/B Ratio1.0
Op. Cash FlowNZ$570.0M
Free Cash FlowNZ$-47625000
Technical Analysis
TrendNeutral
RSI43.4
SupportNZ$3.26
ResistanceNZ$3.65
MA 20NZ$3.48
MA 50NZ$3.66
MA 200NZ$3.33
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair ValueNZ$2.87
Target PriceNZ$3.59
Upside/Downside5.01%
GradeFair
TypeValue
Risk Assessment
Beta0.23
Volatility29.85%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.